Compare Ginkgo Bioworks Holdings Inc (DNA) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| DNA | USIG | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Fixed Income |
52-Week High | $16.14 | $52.69 |
52-Week Low | $5.48 | $50.18 |
Enterprise Value | $607.68M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
